CELLSOURCE
CELLSOURCE
Industry:
Clinical Trials Medical Device
Founded:
2015-11-30
Status:
Active
Technology used in webpage:
Viewport Meta Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Nginx Euro Google Maps US Privacy User Signal Mechanism
Current Advisors List
Current Employees Featured
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-16 | Cuorips, Inc. | CellSource investment in Venture Round - Cuorips, Inc. | 1.6 B JPY |
More informations about "CellSource"
Governance | Sustainability | CellSource Co., Ltd.
CellSource positions corporate governance as the core of the business essential for the Company to continue making profits and improving sustainability and developing an organizational …See details»
CellSource - Crunchbase Investor Profile & Investments
CellSource provides adipose-derived stem cell processing services, blood-derived processing contract services, and support services for compliance with laws and regulations in areas such …See details»
CellSource Co., Ltd. (4880.T) Company Profile & Facts - Yahoo …
See the company profile for CellSource Co., Ltd. (4880.T) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
CellSource Company Description - Stock Analysis
Dec 27, 2024 CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from …See details»
CellSource - Products, Competitors, Financials, Employees, …
CellSource is a company focused on regenerative medicine, operating as a platform in the healthcare sector. Use the CB Insights Platform to explore CellSource's full profile. ... The …See details»
Cell Source - Crunchbase Company Profile & Funding
Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology …See details»
Cell Source, Inc. – Safer Next-Generation Immunotherapy
Cell Source ’ s safe organ transplantation approach utilizes Veto cells’ selective immune targeting to enable the transplant recipient ’ s immune system to permanently accept organs from partially-matched donors. This eliminates the …See details»
CellSource: Unlocking the potential of regenerative …
Apr 29, 2020 CellSource has collaborated with various medical institutions and research institutions to establish a state-of-the-art platform in regenerative medicine that is available for all to utilize. Regenerative medicine is moving …See details»
About Us - CellSource Co., Ltd.
CellSource Company Information.See details»
CellSource Co., Ltd. - Shared Research
CellSource Co., Ltd. (TSE Prime: 4880) is a biotech company specializing in regenerative medicine. The company’s origin dates back to 2014, when the Japanese government enacted …See details»
CEO Message - CellSource Co., Ltd.
Since founding in 2015, we at CellSource have developed our business with a focus on regenerative medicine-related services. Regenerative medicine, particularly in the field of …See details»
CellSource Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 CellSource has 5 employees at their 1 location and ¥4.51 b in annual revenue in FY 2023. See insights on CellSource including office locations, competitors, revenue, …See details»
CellSource Launches New Subsidiary for Medical Collaboration
Oct 31, 2024 CellSource Co., Ltd. has announced the establishment of a new subsidiary, Hybrid Medical Co., Ltd., to enhance collaboration with medical institutions in regenerative medicine, …See details»
CellSource (TSE:4880) - Stock Price, News & Analysis - Simply Wall St
Dec 13, 2024 CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from …See details»
Cell Source Company Profile - Office Locations, Competitors
Oct 29, 2024 Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto …See details»
Sustainability | CellSource Co., Ltd.
“HSF management” is our management policy based on the idea that sustained growth of CellSource centered on HSF synchronizes with the creation of a sustainable society and …See details»
AABB CellSource
Each month, AABB CellSource features: BIOTHERAPIES NEWS: highlights and top stories from the biotherapies field; BIOTHERAPIES AT AABB: community and association news ... not-for …See details»
Molecular and cellular dynamics of the developing human neocortex
1 day ago Tripotential intermediate progenitor cells are responsible for the local production of GABAergic neurons, oligodendrocyte precursor cells and astrocytes in the human …See details»
Environment | Sustainability | CellSource Co., Ltd.
Impact on the organization’s strategy, financial planning, etc. The Company is aware that we need to follow regulatory developments closely, bearing in mind the possibility that new, tougher …See details»
HSF Management - CellSource Co., Ltd.
CellSource: Goals : Unclear: Crystal clear: Action: Do all that seems important: Do only what must be done: Time Management: Chaotic schedule: Self-managed schedule: Thinking: Think …See details»